Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Hala T. Borno"'
Autor:
Tanya Jindal, Xiaolin Zhu, Rohit Bose, Vipul Kumar, Edward Maldonado, Prianka Deshmukh, Chase Shipp, Stephanie Feng, Michelle S. Johnson, Austin Angelidakis, Daniel Kwon, Hala T. Borno, Ivan de Kouchkovsky, Arpita Desai, Rahul Aggarwal, Lawrence Fong, Eric J. Small, Anthony Wong, Sima Porten, Jonathan Chou, Terence Friedlander, Vadim S. Koshkin
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundEnfortumab vedotin (EV) is an antibody-drug conjugate approved for patients with treatment-refractory advanced urothelial carcinoma (aUC), however data on biomarkers of response is lacking.MethodsWe retrospectively identified all aUC patien
Externí odkaz:
https://doaj.org/article/807b9f7db97e495ebdc50bd69421c109
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundThe treatment of metastatic prostate cancer has been revolutionized with the advent of many targeted therapies, including immunotherapy. Pembrolizumab has demonstrated benefit in the treatment of certain patients with docetaxel-refractory m
Externí odkaz:
https://doaj.org/article/e5d6ffad400b4113a2b98b0d6b519478
Autor:
Stacy Loeb, Rada Mihalcea, Veronica Perez-Rosas, Alex Xu, Jacob Taylor, Nataliya Byrne, Dawn Walter, Marina Ness, Rebecca Robbins, Sylvia Zhang, Trevor Killeen, Divya Natesan, Hala T. Borno
Publikováno v:
European Urology Open Science, Vol 25, Iss , Pp 1-4 (2021)
The COVID-19 pandemic dramatically impacted society and health care on a global scale. To capture the lived experience of patients with prostate cancer and family members/caregivers during the COVID-19 pandemic, we performed a mixed-methods study of
Externí odkaz:
https://doaj.org/article/82699bbdc28844ee9abcacdd2571561e
Autor:
Mary Kathryn Abel, Michelle E. Melisko, Hope S. Rugo, A. Jo Chien, Italia Diaz, Julia K. Levine, Ann Griffin, Joseph McGuire, Laura J. Esserman, Hala T. Borno, Rita A. Mukhtar
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-3 (2021)
Abstract Enrollment in metastatic breast cancer trials usually requires measurable lesions, but patients with invasive lobular carcinoma (ILC) tend to form diffuse disease. We found that the proportion of patients with metastatic ILC enrolled in clin
Externí odkaz:
https://doaj.org/article/5ae74b962d5a4b5e99550871185eb4e4
Autor:
Hala T. Borno, Brian M. Bakke, Celia Kaplan, Anke Hebig-Prophet, Jessica Chao, Yoon-Ji Kim, Jan Yeager, Pelin Cinar, Eric Small, Christy Boscardin, Ralph Gonzales
Publikováno v:
Pilot and Feasibility Studies, Vol 5, Iss 1, Pp 1-8 (2019)
Abstract Background Recruitment of a diverse participant pool to cancer clinical trials is an essential component of clinical research as it improves the generalizability of findings. Investigating and piloting novel recruitment strategies that take
Externí odkaz:
https://doaj.org/article/1738486abd1b485185255e75dd916332
Autor:
Hannah M. Dragomanovich, Anand Dhruva, Eve Ekman, Kelly L. Schoenbeck, Ai Kubo, Erin L. Van Blarigan, Hala T. Borno, Mikaela Esquivel, Bryant Chee, Matthew Campanella, Errol J. Philip, John P. Rettger, Blake Rosenthal, Katherine Van Loon, Alan P. Venook, Christy Boscardin, Patricia Moran, Frederick M. Hecht, Chloe E. Atreya
Publikováno v:
Global Advances in Health and Medicine, Vol 10 (2021)
Purpose A metastatic cancer diagnosis is associated with high levels of distress in patients and caregivers, which may be alleviated by mindfulness interventions. Research on scalable, tailored, online mindfulness training programs is needed. We soug
Externí odkaz:
https://doaj.org/article/c7915925f8f748679a077124e599447e
Publikováno v:
Cancer Reports, Vol 4, Iss 4, Pp n/a-n/a (2021)
Abstract Background Patients with cancer are particularly vulnerable in the current COVID‐19 pandemic. Emerging evidence suggests that patients with a cancer diagnosis are three times more likely to die from COVID‐19 compared to non‐cancer pati
Externí odkaz:
https://doaj.org/article/4790819f3813493d93236f52f959c809
Publikováno v:
Pilot and Feasibility Studies, Vol 5, Iss 1, Pp 1-7 (2019)
Abstract Background The evidence-based practice of active surveillance to monitor men with favorable-risk prostate cancer in lieu of initial definitive treatment is becoming more common. However, there are barriers to effective implementation, partic
Externí odkaz:
https://doaj.org/article/70e4cfe54b2049d3a799eb5a31484796
Publikováno v:
Contemporary Clinical Trials Communications, Vol 19, Iss , Pp 100630- (2020)
Background: Racial/ethnic disparities in disease burden have gained the spotlight in the United States with the spread of SARS-CoV-2 and surge of COVID-19 cases. The problem of underrepresentation in clinical research persists today. In light of the
Externí odkaz:
https://doaj.org/article/29d95abbc7564aafaf208efc85d146af
Autor:
Hala T. Borno, Eric J. Small, Li Zhang, Mindy C. DeRouen, Ann Griffin, Joseph McGuire, Charles J. Ryan, Robert A. Hiatt, Celia P. Kaplan
Publikováno v:
Contemporary Clinical Trials Communications, Vol 16, Iss , Pp - (2019)
Background: A lack of diversity among clinical trial (CT) participants remains a critical problem. Few studies have examined recruitment variability in cancer treatment CTs by cancer type. Given the increasing organ-specific specialization of oncolog
Externí odkaz:
https://doaj.org/article/4f037297199a413ebbb86e12715b95e4